Healthcare News

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

LAWRENCEVILLE, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that the Company...

"(The findings) provide strong scientific evidence...for the administration of PRP as a stand-alone therapy, but also as a combinatorial approach"

The audited report from one of the UK's largest and fastest growing Waqf funds, details £3.7 million invested in during 2025.

UroGen first patient dosed in UGN-501 Phase 1 trial

Oral tablet form expected to allow Company to optimize patient plasma exposure levels with convenient daily dosing of drug Sustained plasma levels of elraglusib expected to have multiple effects on...

Matt Franklin joins A3P Biomedical as President, North America to accelerate U.S. market access for Stockholm3.

WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis...

Predictive Interim analysis indicates low probability of study meeting its primary efficacy endpoint if continuedComprehensive analysis and evaluation of available open-label extension data will...

The SEC has declared effective the Form S-4 Registration Statement and definitive proxy for the proposed merger between Chemomab and Scipher Medicine.